U.S. Physical Therapy, Inc. USPH
$83.08
-$0.31-0.37%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 176.67M | 162.32M | 167.94M | 161.95M | 162.19M |
| Total Other Revenue | 35.27M | 33.96M | 33.05M | 33.11M | 33.16M |
| Total Revenue | 211.94M | 196.28M | 201.00M | 195.06M | 195.35M |
| Cost of Revenue | 164.37M | 157.94M | 156.58M | 152.73M | 147.92M |
| Gross Profit | 47.57M | 38.34M | 44.42M | 42.33M | 47.43M |
| SG&A Expenses | 18.37M | 18.27M | 18.13M | 17.41M | 17.14M |
| Depreciation & Amortization | 5.62M | 5.66M | 4.28M | 5.50M | 5.74M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 188.36M | 181.87M | 178.99M | 175.64M | 170.80M |
| Operating Income | 23.58M | 14.41M | 22.01M | 19.42M | 24.55M |
| Income Before Tax | 19.05M | 10.56M | 14.96M | 22.88M | 22.65M |
| Income Tax Expenses | 4.16M | 2.41M | 5.78M | 5.23M | 4.93M |
| Earnings from Continuing Operations | 14.90M | 8.16M | 9.18M | 17.64M | 17.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.00M | -3.12M | -5.02M | -4.50M | -5.33M |
| Net Income | 9.90M | 5.04M | 4.15M | 13.14M | 12.39M |
| EBIT | 23.58M | 14.41M | 22.01M | 19.42M | 24.55M |
| EBITDA | 29.52M | 20.41M | 26.64M | 25.25M | 30.61M |
| EPS Basic | 0.25 | -0.12 | -0.43 | 0.48 | 0.58 |
| Normalized Basic EPS | 0.53 | 0.31 | 0.50 | 0.40 | 0.57 |
| EPS Diluted | 0.25 | -0.12 | -0.43 | 0.48 | 0.58 |
| Normalized Diluted EPS | 0.53 | 0.31 | 0.50 | 0.40 | 0.57 |
| Average Basic Shares Outstanding | 15.07M | 15.17M | 15.17M | 15.20M | 15.20M |
| Average Diluted Shares Outstanding | 15.07M | 15.17M | 15.17M | 15.20M | 15.20M |
| Dividend Per Share | 0.46 | 0.46 | 0.45 | 0.45 | 0.45 |
| Payout Ratio | 140.14% | -- | 164.75% | 52.08% | 110.37% |